Key Financial Results (Quarter Ended June 30, 2026)

Revenue & Profitability:

  • Revenue from Operations: ₹46,192.81 lakhs (₹461.93 crore)
  • Other Income: ₹886.28 lakhs (₹8.86 crore)
  • Total Income: ₹47,079.09 lakhs (₹470.79 crore)
  • Profit Before Tax: ₹4,857.36 lakhs (₹48.57 crore)
  • Tax Expense: ₹1,226.92 lakhs (₹12.27 crore)
  • Net Profit for the quarter: ₹3,630.44 lakhs (₹36.30 crore)
  • Total Comprehensive Income: ₹3,630.44 lakhs (₹36.30 crore)

Earnings Per Share:

  • Basic EPS: ₹8.06
  • Diluted EPS: ₹8.06

Comparative Performance:

  • Revenue decreased from ₹52,828.81 lakhs in Q1 FY26 and ₹48,333.67 lakhs in Q4 FY26
  • Net profit decreased from ₹5,550.34 lakhs in Q1 FY26 and ₹9,777.06 lakhs in Q4 FY26

Capital Structure:

  • Paid-up equity share capital: ₹891.57 lakhs (face value ₹2 per share)
  • Other Equity (as per audited balance sheet): ₹1,67,286.30 lakhs

Strategic Decisions & Corporate Actions

1. New Manufacturing Unit Approval:

  • Investment of up to ₹200 crore for setting up pesticide manufacturing unit at Nagpur, Maharashtra
  • Proposed capacity: 23,000 MT per annum
  • Expected operational date: March/April 2028
  • Mode of financing: Internal accruals and/or debt
  • Rationale: Proximity to prime markets in South, East and Central India; logistical advantages; attractive Maharashtra industrial policies; Nagpur's development as logistics hub under Viksit Nagpur plan

2. Employee Stock Appreciation Rights Plan:

  • Loan of up to ₹15 crore sanctioned to Dhanuka Employee Stock Benefits Trust
  • Purpose: Implementation and administration of "Dhanuka Stock Appreciation Rights Plan, 2026" (SAR 2026)
  • Fund utilization: Acquisition/holding of equity shares from open market and plan administration
  • Repayment: As per terms of Loan Agreement to be executed
  • Regulatory framework: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

3. Share Buyback Completion:

  • During the quarter ended June 30, 2026, company bought back 5,00,000 fully paid-up equity shares
  • Buyback price: ₹1,400 per equity share
  • Total buyback amount: ₹70.00 crore
  • Percentage of share capital: 1.11% of total issued and paid-up equity share capital
  • Shares extinguished on: June 20, 2026
  • Paid-up share capital reduced by: ₹10,00,000

Additional Information

Meeting Details:

  • Board meeting commenced at 12:30 PM (IST) and concluded at 2:00 PM (IST) on August 3, 2026

Regulatory Compliance:

  • Financial results reviewed by Audit Committee and approved by Board of Directors
  • Statutory Auditors (S S Kothari Mehta & Co. LLP) conducted limited review of financial results
  • Filed pursuant to Regulation 30 of SEBI Listing Regulations

Business Segment:

  • Single reportable business segment: "Agro Chemicals"
  • Business dependent on monsoon, pest infestation and crop patterns, causing period-to-period variations

Investor Access:

  • Results available on company website www.dhanuka.com and stock exchange websites www.bseindia.com, www.nseindia.com
  • Investor queries can be sent to investors@dhanuka.com